Freestone Capital Holdings »

ZIOPHARM Oncology shares owned by Freestone Capital Holdings

Quarter-by-quarter ownership of ZIOPHARM Oncology shares owned by Freestone Capital Holdings from 13F filings

Historical chart of Freestone Capital Holdings investment in ZIOPHARM Oncology

Tip: Access up to 7 years of quarterly data

All positions including ZIOPHARM Oncology held by Freestone Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ZIOPHARM Oncology by Freestone Capital Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.3k 10k 0.13
2023-06-30 $5.1k 10k 0.51
2023-03-31 $6.3k 10k 0.63
2022-12-31 $6.5k 10k 0.65
2022-09-30 $17k 10k 1.70
2022-06-30 $12k 10k 1.20
2022-03-31 $7.0k 10k 0.70
2021-12-31 $11k 10k 1.10

More positions owned by Freestone Capital Holdings

Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Apple (AAPL)
Nike CL B (NKE)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Costco Wholesale Corporation (COST)

View all positions for Freestone Capital Holdings

Top funds holding ZIOPHARM Oncology

MSDC Management
Vanguard Group
Discovery Capital Management
Advisor Group Holdings
Squarepoint Ops
Commerce Bank N A
Magnolia Capital Advisors
Two Sigma Investments
Two Sigma Securities
Citadel Advisors
UBS Group
Atria Wealth Solutions
Charles Schwab Investment Management
Wells Fargo & Company
Franklin Resources

View all funds holding ZIOPHARM Oncology